Literature DB >> 7148360

Pharmacological evacuation of the stomach with metoclopramide.

G L Olsson, B Hallén.   

Abstract

Children admitted for emergency operations because of trauma run a high risk of chemical aspiration pneumonitis syndrome. Fifty-eight children admitted for closed reduction of fractures and suturing of wounds were studied in a double-blind manner in order to see if metoclopramide could be of value in decreasing the risk of aspiration during anaesthesia. Metoclopramide given before anaesthesia proved to enhance gastric evacuation and could thus be of value in these situations. In addition, the study showed that the time from last oral intake until start of anaesthesia is of less importance then the type of trauma in prolonging the gastric emptying time and thus increasing the risk of vomiting and aspiration of vomitus into the lungs during anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7148360     DOI: 10.1111/j.1399-6576.1982.tb01791.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  4 in total

1.  Gastric fluid volume, pH, and emptying in elective inpatients. Influences of narcotic-atropine premedication, oral fluid, and ranitidine.

Authors:  J R Maltby; N Koehli; A Ewen; E A Shaffer
Journal:  Can J Anaesth       Date:  1988-11       Impact factor: 5.063

2.  Comparison of the effect of cisapride and metoclopramide on morphine-induced delay in gastric emptying.

Authors:  D J Rowbotham; P A Bamber; W S Nimmo
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

Review 3.  Large volume gastroesophageal reflux: a rationale for risk reduction in the perioperative period.

Authors:  J F Hardy
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

Review 4.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.